Could the immune checkpoint inhibitor against colorectal cancer in constitutional mismatch repair deficiency syndrome prevent new cancer formation?-Reference-Cited by-同舟云学术

Could the immune checkpoint inhibitor against colorectal cancer in constitutional mismatch repair deficiency syndrome prevent new cancer formation?

Published:2021-08-28 Issue:1 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Tanimura Kazuki¹^ORCID,Yamasaki Kai¹,Matsubara Kohei¹,Noguchi Mayuko¹,Kikuchi Natsumi¹,Nitani Chika¹,Okada Keiko¹,Fujisaki Hiroyuki¹,Okuno Takahiro²,Inoue Takeshi²,Nebiki Hiroko³,Akagi Kiwamu⁴,Tomita Naohiro⁵,Hara Junichi¹

Affiliation:

1. Department of Pediatric Hematology and Oncology Children's Medical Center, Osaka City General Hospital Osaka Japan

2. Department of Diagnostic Pathology Osaka City General Hospital Osaka Japan

3. Department of Gastroenterology Osaka City General Hospital Osaka Japan

4. Division of Molecular Diagnosis and Cancer Prevention Saitama Cancer Center Saitama Japan

5. Cancer Treatment Center Toyonaka Municipal Hospital Osaka Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29312

Reference15 articles.

1. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy

2. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency

3. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

4. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)

5. Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention